Header Logo

Connection

TAO WU to Drug Resistance, Neoplasm

Back to Details
This is a "connection" page, showing publications TAO WU has written about Drug Resistance, Neoplasm.
TAO WU
Connection Strength
0.040
Drug Resistance, Neoplasm
  1. A Phase Ib Study of Linperlisib in the Treatment of Patients with Relapsed and/or Refractory Peripheral T-cell Lymphoma. Clin Cancer Res. 2024 Oct 15; 30(20):4593-4600.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.